Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Alcohol

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ALCOHOL.2004.07.005PMID 15670663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.

  2003cited by this paper
• Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice*

  2003cited by this paper
• Central role of PPARα‐dependent hepatic lipid turnover in dietary steatohepatitis in mice

  2003cited by this paper
• PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effect

  2003cited by this paper
• PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.

  2003cited by this paper
• PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

  2003cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.

  2003cited by this paper
• Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.

  2002cited by this paper
• Mechanism for Peroxisome Proliferator-activated Receptor-α Activator-induced Up-regulation of UCP2 mRNA in Rodent Hepatocytes*

  2002cited by this paper
• Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)*

  2002cited by this paper
• WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.

  2002cited by this paper
• WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo1

  2002cited by this paper
• Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice1

  2002cited by this paper
• Effect of fenofibrate on fatty liver in rats treated with alcohol.

  2001cited by this paper
• Tumor necrosis factor α is not required for WY14,643-induced cell proliferation

  2001cited by this paper
• Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice.

  2001cited by this paper
• The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver.

  2001cited by this paper
• Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation.

  2001cited by this paper
• The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver*

  2000cited by this paper
• The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease.

  2000cited by this paper
• Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting*

  2000cited by this paper
• A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• The regulation of acetyl-CoA carboxylase--a potential target for the action of hypolipidemic agents.

  1999cited by this paper
• Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).

  1998cited by this paper
• Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)*

  1998cited by this paper
• Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.

  1997cited by this paper
• Fatty acid activation of peroxisome proliferator-activated receptor (PPAR).

  1995cited by this paper
• Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease.

  1994cited by this paper
• Future directions for research

  1993cited by this paper
• Alcohol consumption enhances fatty acid ω‐oxidation, with a greater increase in male than in female rats

  1993cited by this paper
• A probable defect in the β-oxidation of lipids in rats fed alcohol for 6 months

  1991cited by this paper
• A probable defect in the beta-oxidation of lipids in rats fed alcohol for 6 months.

  1991cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Fatty acid‐binding protein: A major contributor to the ethanol‐induced increase in liver cytosolic proteins in the rat

  1987cited by this paper
• Decrease of Ethanol-Induced Fatty Liver by Ethyl α-p-Chlorophenoxyisobutyrate.∗

  1966cited by this paper

• Sanghuangporus vaninii polysaccharide attenuates chronic alcohol-induced liver injury based on modulation of AMPK/PPARα signaling pathway

  2026cites this paper
• Smoking and Risk of Fatty Liver Disease: A Meta-Analysis of Cohort Studies

  2025influential citation
• Prevalence of Non-alcoholic Fatty Liver Disease - A Population Based Study

  2024cites this paper
• Hepatoprotective effects and mechanisms of l-theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats.

  2024cites this paper
• Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics

  2024cites this paper
• Can Zinc Supplementation Attenuate High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease?

  2023cites this paper
• 4-Hydroxynonenal Is Linked to Sleep and Cognitive Disturbances in Children: Once upon the Time of COVID-19

  2023cites this paper
• Daucosterol Alleviates Alcohol−Induced Hepatic Injury and Inflammation through P38/NF−κB/NLRP3 Inflammasome Pathway

  2023cites this paper
• Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis

  2023cites this paper
• Lipid metabolic disturbance induced by triphenyl phosphate and hydroxy metabolite in HepG2 cells.

  2023cites this paper
• Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy

  2022cites this paper
• Association of Hepatic Steatosis With Coronary Artery Disease by Studying the Role of Individual and Demographic Risk Factors

  2022influential citation
• Investigating the effects of Perfluorooctanoic Sulfonate (PFOS) and ethanol on fatty liver disease using a modified NIAAA model.

  2022cites this paper
• Fermented Curcuma longa L. Prevents Alcoholic Fatty Liver Disease in Mice by Regulating CYP2E1, SREBP-1c, and PPAR-α

  2022cites this paper
• Silymarin Dehydroflavonolignans Chelate Zinc and Partially Inhibit Alcohol Dehydrogenase

  2021cites this paper
• Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease

  2021cites this paper
• STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure

  2021cites this paper
• Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver

  2020cites this paper
• NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease

  2020cites this paper
• Targeting Epigenetic Mechanisms to Alleviate Alcoholic Steatosis

  2020cites this paper
• Alcohol-Associated Liver Disease

  2020cites this paper
• Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease

  2020cites this paper
• Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases

  2020cites this paper
• The hepatic lipidome: From basic science to clinical translation.

  2020cites this paper
• Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease.

  2020cites this paper
• Comparison of Computed Tomographic Hounsfield Numbers with Ultrasonographic Categorization of the Fatty Liver Disease

  2020cites this paper
• Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma

  2020cites this paper
• Association of Non-Alcoholic Fatty Liver Disease with Increased Carotid Intima-Media Thickness Considering Other Cardiovascular Risk Factors

  2019cites this paper
• Sirtuin 3-mediated pyruvate dehydrogenase activity determines brown adipocytes phenotype under high-salt conditions

  2019cites this paper
• Differential Metabolism of Medium-Chain Fatty Acids in Differentiated Human-Induced Pluripotent Stem Cell-Derived Astrocytes

  2019cites this paper
• Effect of ethanol on lipid metabolism.

  2019cites this paper
• Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis.

  2019cites this paper
• Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group.

  2019cites this paper
• Sonographic Association between Fatty Liver and Gall Bladder Stones among all Adult Patients Visiting Private Clinics of Lahore City

  2019cites this paper
• Liver Cirrhosis with Steatohepatitis: Nonalcoholic Steatohepatitis and Alcoholic Steatohepatitis

  2019cites this paper
• Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders.

  2019cites this paper
• Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview

  2019cites this paper
• Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention

  2019cites this paper
• TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism

  2018cites this paper
• Genetic and Epigenetic Modifiers of Alcoholic Liver Disease

  2018cites this paper
• Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development

  2018cites this paper
• Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha.

  2018cites this paper
• Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease

  2018cites this paper
• Octopus ( Enterocopus dofleini ) Liver Extract Displays Triglyceride-Lowering Effect in HepG2 Cells

  2017cites this paper
• Anti-steatotic and anti-inflammatory effects of Hovenia dulcis Thunb. extracts in chronic alcohol-fed rats.

  2017cites this paper
• An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of kupffer cell polarization

  2017cites this paper
• Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran

  2017cites this paper
• Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol‐induced hepatocyte steatosis and apoptosis

  2017cites this paper
• Kupffer cells activation promoted binge drinking-induced fatty liver by activating lipolysis in white adipose tissues.

  2017cites this paper
• Ginsenosides from stems and leaves of ginseng prevent ethanol-induced lipid accumulation in human L02 hepatocytes

  2017cites this paper
• Glycemic Status and Lipid Profiles Changes among the Incidentally Diagnosed Fatty Liver Patients

  2017cites this paper
• Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats

  2016cites this paper
• Role of phosphodiesterase-4 in alcohol-induced organ injury.

  2016cites this paper
• Role of Zinc in Alcoholic Liver Disease

  2016cites this paper
• Lipid-liver crosstalk in health and disease

  2016cites this paper
• Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol‐induced steatosis

  2016influential citation
• Cholesterol Regulation by Leptin in Alcoholic Liver Disease

  2016cites this paper
• Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

  2016cites this paper
• Hepatoprotective effects of hoveniae semen cum fructus extracts in ethanol intoxicated mice

  2016cites this paper
• HEPATIC STEATOSIS: AN AETIOHISTOPATHOLOGICAL STUDY

  2016cites this paper
• Characterising granuloma regression and liver recovery in a murine model of schistosomiasis japonica.

  2016cites this paper
• Poor Nutrition Leading to Potential Clinically Relevant Pathologies: The Role of Epigenetics and Myostatin Signalling

  2016cites this paper
• Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

  2015cites this paper
• Bases moléculaires des effets toxiques de l’alcool

  2015cites this paper
• Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease.

  2015cites this paper
• Exacerbation of Insulin Resistance and Hepatic Steatosis Deriving from Zinc Deficiency in Patients with HCV-Related Chronic Liver Disease

  2015cites this paper
• Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK.

  2015cites this paper
• FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice[S]

  2015cites this paper
• Prevalence of fatty liver disease and the economy in China: A systematic review.

  2015cites this paper
• Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress.

  2015cites this paper
• Non Alcoholic Fatty Liver Overview

  2015influential citation
• Dietary Oxidized Lipids as Regulators of Intracellular Signaling Pathways: PPAR and NF-κB

  2015cites this paper
• Serum Metabolomic Profiling in Acute Alcoholic Hepatitis Identifies Multiple Dysregulated Pathways

  2014cites this paper
• Dysregulation of hepatic zinc transporters in a mouse model of alcoholic liver disease.

  2014influential citation
• The “Goldilocks Zone” from a redox perspective—Adaptive vs. deleterious responses to oxidative stress in striated muscle

  2014influential citation
• Evaluation of safety and efficacy of a Polyherbal formulation Liv.52 DS in the Management of Non-Alcoholic Steatohepatitis (NASH): An open clinical study

  2014cites this paper
• CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]

  2014cites this paper
• Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

  2014cites this paper
• Acute Ethanol Causes Hepatic Mitochondrial Depolarization in Mice: Role of Ethanol Metabolism

  2014cites this paper
• CMZ Reversed Chronic Ethanol-Induced Disturbance of PPAR-α Possibly by Suppressing Oxidative Stress and PGC-1α Acetylation, and Activating the MAPK and GSK3β Pathway

  2014cites this paper
• Liver steatosis associated with chronic hepatitis C.

  2014cites this paper
• Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.

  2014cites this paper
• Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

  2014cites this paper
• Immunity and inflammatory signaling in alcoholic liver disease

  2014cites this paper
• The Role of Exercise in Polychlorinated Biphenyl Induced Cardiovascular Disease

  2014cites this paper
• Inflammation and MMPs in alcohol-induced liver diseases and protective action of antioxidants.

  2013cites this paper
• Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice.

  2013cites this paper
• Neuroimmune signaling: a key component of alcohol abuse.

  2013cites this paper
• Nutrition and Alcoholic and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

  2013cites this paper
• Increased plasma corticosterone contributes to the development of alcoholic fatty liver in mice.

  2013cites this paper
• Decrease of fasting blood sugar via garlic supplementation in postmenopausal obese women with osteoarthritis

  2013cites this paper
• Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study

  2013influential citation
• The contribution of vascular adhesion protein-1 to glucose and lipid homeostasis in the liver

  2013cites this paper
• Tissue Distribution and Versatile Functions of PPARs

  2013cites this paper
• Herbal medicines for fatty liver diseases.

  2013cites this paper
• anistic insights into the role of increased glucocorticoid in the development of alcoholic fatty liver

  2013cites this paper
• Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1.

  2012cites this paper
• Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Chronic Alcohol Exposure Stimulates Adipose Tissue Lipolysis in Mice Role of Reverse Triglyceride Transport in the Pathogenesis of Alcoholic Steatosis

  2012cites this paper
• Nuclear receptors and transcription factors in the development of fatty liver disease.

  2012cites this paper
• Toward a Unifying Hypothesis of Metabolic Syndrome

  2012cites this paper